JULIAN
CARRETERO ASUNCION
TITULAR DE UNIVERSIDAD
University of North Carolina at Chapel Hill
Chapel Hill, Estados UnidosPublicaciones en colaboración con investigadores/as de University of North Carolina at Chapel Hill (5)
2016
-
Oncogenic deregulation of EZH2 as an opportunity for targeted therapy in lung cancer
Cancer Discovery, Vol. 6, Núm. 9, pp. 1007-1021
2013
-
Activation of the PD-1 pathway contributes to immune escape in EGFR-driven lung tumors
Cancer Discovery, Vol. 3, Núm. 12, pp. 1355-1363
-
Metabolic and functional genomic studies identify deoxythymidylate kinase as a target in LKB1 -mutant lung cancer
Cancer Discovery, Vol. 3, Núm. 8, pp. 870-879
2010
-
Integrative Genomic and Proteomic Analyses Identify Targets for Lkb1-Deficient Metastatic Lung Tumors
Cancer Cell, Vol. 17, Núm. 6, pp. 547-559
2009
-
HIF2α cooperates with RAS to promote lung tumorigenesis in mice
Journal of Clinical Investigation, Vol. 119, Núm. 8, pp. 2160-2170